A glycogen storage disease type 1a patient with type 2 diabetes

被引:3
|
作者
Sun, Yi [1 ]
Qiang, Wenhui [1 ,2 ]
Wu, Runze [1 ,2 ]
Yin, Tong [1 ]
Yuan, Jie [1 ]
Yuan, Jin [1 ]
Gu, Yunjuan [1 ,3 ]
机构
[1] Nantong Univ, Affiliated Hosp, Dept Endocrinol & Metab, Nantong, Jiangsu, Peoples R China
[2] Nantong Univ, Med Coll, Nantong, Jiangsu, Peoples R China
[3] Nantong Univ, Affiliated Hosp, Dept Endocrinol, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China
关键词
GSD1a; T2DM; G6PC gene; INSULIN-SECRETION; GLUCOSE-6-PHOSPHATASE GENE; IA; SECONDARY; MELLITUS; SENSITIVITY; DIAGNOSIS; MUTATION;
D O I
10.1186/s12920-022-01344-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Glycogen storage disease type 1a (GSD1a) is an inborn genetic disease caused by glucose-6-phosphatase-alpha (G6Pase-alpha) deficiency and is often observed to lead to endogenous glucose production disorders manifesting as hypoglycemia, hyperuricemia, hyperlipidemia, lactic acidemia, hepatomegaly, and nephromegaly. The development of GSD1a with diabetes is relatively rare, and the underlying pathogenesis remains unclear. Case presentation Here we describe a case of a 25-year-old Chinese female patient with GSD1a, who developed uncontrolled type 2 diabetes mellitus (T2DM) as a young adult. The patient was diagnosed with GSD1a disease at the age of 10 and was subsequently treated with an uncooked cornstarch diet. Recently, the patient was treated in our hospital for vomiting and electrolyte imbalance and was subsequently diagnosed with T2DM. Owing to the impaired secretory function of the patient's pancreatic islets, liver dysfunction, hypothyroidism, severe hyperlipidemia, and huge hepatic adenoma, we adopted diet control, insulin therapy, and hepatic adenoma resection to alleviate this situation. The WES discovered compound heterozygous mutations at the exon 5 of G6PC gene at 17th chromosome in the patient, c.648G>T (p.L216 L, NM_000151.4, rs80356484) in her father and c.674T>C (p.L225 P, NM_000151.4, rs1555560128) in her mother. c.648G>T is a well-known splice-site mutation, which causes CTG changing to CTT at protein 216 and creates a new splicing site 91 bp downstream of the authentic splice site, though both codons encode leucine. c.674T>C is a known missense mutation that causes TGC to become CGC at protein 225, thereby changing from coding for leucine to coding for proline. Conclusion We report a rare case of GSD1a with T2DM. On the basis of the pathogenesis of GSD1a, we recommend attentiveness to possible development of fasting hypoglycemia caused by GSD and postprandial hyperglycemia from diabetes. As the disease is better identified and treated, and as patients with GSD live longer, this challenge may appear more frequently. Therefore, it is necessary to have a deeper and more comprehensive understanding of the pathophysiology of the disease and explore suitable treatment options.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] A glycogen storage disease type 1a patient with type 2 diabetes
    Yi Sun
    Wenhui Qiang
    Runze Wu
    Tong Yin
    Jie Yuan
    Jin Yuan
    Yunjuan Gu
    BMC Medical Genomics, 15
  • [2] Diabetes in a Patient with Glycogen Storage Disease Type 1a
    Kanemaru, Yoshinori
    Harada, Norio
    Wada, Naoki
    Yasuda, Takuma
    Okamura, Emi
    Fujii, Toshihito
    Ogura, Masahito
    Inagaki, Nobuya
    INTERNAL MEDICINE, 2024, 63 (15) : 2153 - 2156
  • [3] Acute pancreatitis in a patient with glycogen storage disease type 1a
    Hirashima, Kaname
    Kido, Jun
    Matsumoto, Shirou
    Nakamura, Kimitoshi
    PEDIATRICS AND NEONATOLOGY, 2019, 60 (03): : 348 - 349
  • [4] Castleman's Disease in a Patient with Glycogen Storage Disease Type 1A
    Cuglievan, B.
    Triche, L.
    Rytting, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S178 - S178
  • [5] A novel mutation in a Brazilian patient with glycogen storage disease type 1a
    Sartorato, EL
    Reis, FC
    Norato, DYJ
    Hackel, C
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (04) : 447 - 447
  • [6] ACQUIRED VON WILLEBRAND DISEASE IN A PATIENT WITH GLYCOGEN STORAGE DISEASE TYPE 1A
    Balci, Y. I.
    Sarbay, H.
    Polat, A.
    Akin, M.
    THROMBOSIS RESEARCH, 2016, 141 : S85 - S85
  • [7] Cerebrovascular disease in type 1A glycogen storage disease
    Berzsenyi, MD
    Brady, BMR
    O'Donnell, CJ
    Frayne, JH
    JOURNAL OF CLINICAL NEUROSCIENCE, 1998, 5 (01) : 93 - 94
  • [8] Glucose levels controlled with an insulin pump in a patient with combined glycogen storage disease type 1a and type 1 diabetes mellitus
    Potter, M. A.
    Khan, A. A.
    Pelletier, H.
    van der Meulen, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 123 - 123
  • [9] Multidisciplinary management of pregnancy and labour in a patient with glycogen storage disease type 1a
    Jones, Alice May
    Tower, Clare
    Green, Diane
    Stepien, Karolina M.
    BMJ CASE REPORTS, 2021, 14 (08)
  • [10] Calcium kinetics in glycogen storage disease type 1a
    Goans, RE
    Weiss, GH
    Vieira, NE
    Sidbury, JB
    Abrams, SA
    Yergey, AL
    CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (06) : 449 - 453